Tg Therapeutics Inc (TGTX)

EBITDA Growth

37.40%

TTM · Period ending:

TGTX logo

TGTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported37.40%
TGTX TTM EBITDA YoY % (-82.14% → 37.40%)
High-resolution chart · PNG

TGTX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Tg Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
95.4023%
41.2626%
-10.2285%
-100.9383%
-50.9054%
-45.5761%
-12%
9.0909%
-19.3548%
60.7143%
50.9804%
29.7872%
35.4167%
-51.3514%
-82.1429%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.